Julia Lainster

In the critical moments of treating a suspected opioid overdose, where every second counts, a new study reveals that a common vital sign could be the key to uncovering a hidden and far more complex danger. A groundbreaking investigation suggests that an unusually slow pulse might be the first clear

The promise of affordable elective surgery in an exotic location has captivated a growing number of patients, but a closer examination reveals a far more complex and costly reality hidden behind the glossy brochures and enticing online advertisements. This burgeoning global industry, built on the

We sit down with Biopharma expert Ivan Kairatov to discuss a recent study that uncovers a critical vulnerability in acute myeloid leukemia (AML), a notoriously difficult-to-treat blood cancer. This research zeroes in on the survival mechanisms of resilient leukemia stem cells, identifying a key

Today we're joined by Ivan Kairatov, a Biopharma expert at the forefront of integrating technology and innovation into medical training. We’ll be exploring a groundbreaking initiative that uses ambient AI to transform medical education, moving from sporadic feedback to a model where every clinical

Today we sit down with Dr. Ivan Kairatov, a veteran biopharma expert whose work at the intersection of medicinal chemistry and computational biology is pushing the boundaries of treatment for central nervous system disorders. For decades, the neurokinin-1 receptor, or NK1R, was a tantalizing but

As millions of people around the globe clock in for shifts that extend into the late hours and overnight, a large-scale study has revealed a concerning and previously underappreciated occupational hazard connected to their work schedules. This comprehensive investigation provides significant new

The long-standing, methodical pace of clinical drug development may soon be disrupted by a statistical revolution endorsed at the highest regulatory levels, promising to make trials more flexible, efficient, and patient-focused. For decades, the path to drug approval has been paved with rigid,

The allure of a cut-price cosmetic procedure or weight-loss surgery abroad often masks a harsh reality, one where complications can leave UK patients facing a health crisis and the National Health Service footing a bill that can spiral into tens of thousands of pounds. This growing trend of

The biopharmaceutical manufacturing sector is currently grappling with a legacy of outdated, fragmented quality control methods that create significant production delays and impose a staggering financial burden on the industry. These traditional, off-line testing protocols, which often rely on

A formidable new strategy has emerged in the fight against a particularly stubborn form of lung cancer, offering a beacon of hope for patients whose tumors have developed resistance to frontline treatments. Researchers from the Medical University of Vienna have pioneered a novel combination therapy